Lamisil Dermgel (Terbinafine)

Terbinafine inhibits the fungal enzyme squalene epoxidase, which is essential for ergosterol synthesis. Blocking this step leads to a buildup of squalene and a shortage of ergosterol, compromising the fungal cell membrane and resulting in fungal cell death.

The prescribed amount of Lamisil Dermgel is determined by the treating clinician based on the infection type, severity, and patient characteristics. The product is applied as a thin layer to the affected skin once daily for the duration specified by the prescriber.

Safety data for topical terbinafine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with azole creams, terbinafine has a different mechanism—blocking squalene epoxidase—and often achieves faster clinical cure rates for dermatophyte infections. It is generally well‑tolerated and requires once‑daily application, whereas some alternatives may need multiple daily doses.

Store Lamisil Dermgel at room temperature, below 25 °C. Keep the tube in its original packaging, protect it from moisture and direct heat, and ensure the cap is tightly closed to maintain product stability.

Clean and dry the affected skin area before use. Apply a thin layer of the gel to the lesion and a small margin of surrounding skin, gently rub it in, and wash hands after application. Follow the prescriber’s instructions regarding frequency and treatment duration.

While rare, serious adverse reactions can include severe allergic responses such as angioedema or anaphylaxis, extensive contact dermatitis, and, in exceptional cases, systemic effects like liver enzyme elevation. Patients should seek immediate medical attention if they experience signs of a serious reaction.

Individuals with known hypersensitivity to terbinafine or any component of the gel should avoid its use. It is also contraindicated on extensive broken skin, large areas of damaged epidermis, or when systemic terbinafine therapy is already being administered.